Features

MAHF 2015: An Evening of Icons

MAHF 2015: An Evening of Icons

The industry celebrated its most precious asset—its people—at The Pierre in New York City on February 3 with a dinner honoring the two most recent inductees to the Medical Advertising Hall of Fame and the 2015 "Future Famers"

How to Win an MM&M Award: 2015

How to Win an MM&M Award: 2015

You have fewer than six weeks to enter the MM&M Awards. No problem. Follow our checklist of Do's and Don'ts and tune in to our webcast on March 24 for more tips.

Multichannel Marketing: Multichannel Matures

Multichannel Marketing: Multichannel Matures

Most healthcare marketers understand the need for their programs to live in a range of channels. Now comes the hard part: Balancing their efforts across the multichannel spectrum. Michael Spitz offers some advice to marketers who get the "why" but need some help with the "how"

Marketing Research: Collaboration Proclamation

Marketing Research: Collaboration Proclamation

The combination of EHR, sensor and biomarker data is working to break down traditional barriers to collaboration among top-flight HEOR researchers

Mobile Marketing: It's Go Time

Mobile Marketing: It's Go Time

The sales reps are game, the HCPs are receptive and the mobile technology is ready. Rebecca Mayer Knutsen reports on the circumstances that have converged to provide pharma with its most promising mobile selling moment to date

Therapeutic Focus: Metabolic

Therapeutic Focus: Metabolic

Is this finally the year that anti-obesity drugs make the leap from niche curio to mainstream therapy? Frank Celia reports on the changing practitioner mind-set that could shift odds in favor of several new weight-loss options

Formulary Fireworks

Formulary Fireworks

By

In the wake of the high-profile showdown between Gilead and Express Scripts over the pricing of hepatitis-C drugs Sovaldi and Harvoni, the pharma/PBM balance of power may well have shifted—but not to the degree that many observers had predicted

Journal Ad Review: Back in the Mix

Journal Ad Review: Back in the Mix

A few years ago medical publishers were approaching a cliff and the choices were simple: Evolve the business or fall over the edge. By having learned to survive, some publishers are now ready to thrive

MM&M Awards—Fields of Gold

MM&M Awards—Fields of Gold

The MM&M Awards 2015 program is officially open for business

Nothing (Im)personal

Nothing (Im)personal

With unprecedented numbers of practices locking out sales reps, pharma companies are being forced to do a better job of engaging HCPs in other ways

Hot Space

Hot Space

Our second annual survey of patients, physicians and payers reveals a significant degree of frustration—on every side—in an around the ever-booming specialty drug segment. Sarah Morgan interprets the results

Men of Agency

Men of Agency

Francis Gace and Dr. H. James Barnum took different paths to the top but each left a lasting mark on the advertising business. Barbara Peck celebrates the legacies of the two latest inductees to the Medical Advertising Hall of Fame

Mobile Marketing Report: On Hold

Mobile Marketing Report: On Hold

By

It's not as though pharma marketers didn't see mobile coming. For the past half decade, they've discussed its potential to transform behaviors and relationships within the healthcare ecosystem. Yet now that mobile has arrived, they find themselves torn between caution and exuberance. Larry Dobrow explains

Therapeutic Focus: Rare Diseases

Therapeutic Focus: Rare Diseases

The rare disease drug market is making history with its steady growth and burgeoning pipeline—and owing to continuing breakthroughs in gene therapy, the biggest advances are yet to come. Rebecca Mayer Knutsen reports on a sector that is thriving—and on the possibility that issues around pricing can slow its surge.

The Top 40 Healthcare Transformers

The Top 40 Healthcare Transformers

By

Change within a set-in-its-ways industry can be scary—that is, unless you've got the will and bravado to tackle it head-on. Here are the 40 inventors, ­strategists, advocates and wonks who are challenging, disrupting and otherwise transforming the healthcare business.

Communication Shakedown

Communication Shakedown

Long the only game in town, health insurers—many have observed—never mastered the art of customer service. But with a host of tech- and service-savvy upstarts making plays for "their" customers, the rules have changed. Sarah Mahoney examines how the new breed of insurers—who mix high tech with high touch—are trying to outflank the establishment

Therapeutic Focus: Cardiovascular

Therapeutic Focus: Cardiovascular

The cardiovascular space has long ranked among the pharma industry's most vibrant. Even by that standard, however, 2015 is shaping up as a blockbuster year, and PCSK9 inhibitors have a lot to do with projections. Estimates for their success could prove even better if they are shown to reduce cardiovascular event risk, as well. Joe Dysart explains

"I" in the Sky

"I" in the Sky

In theory, healthcare marketers love the idea of beacons. In practice? Well, nobody's sure whether patients and physicians will be wowed by their utility or turned off by their invasiveness. Barbara Peck offers a Beacons 101 primer

Outlook 2015: The Tax Man Cometh

Outlook 2015: The Tax Man Cometh

By

For years, Congress has batted around the possibility of tax reform—and with it, the reduction or elimination of the tax deduction for marketing expenses. Could 2015 be the year that reform comes to pass? Larry Dobrow attempts to answer this and other pressing policy questions

Outlook 2015: Street Science

Outlook 2015: Street Science

By

Buoyed by unprecedented success in hepatitis C, the biotech and pharma sectors had a strong 2014. And to hear ace Evercore ISI analyst Dr. Mark Schoenebaum tell it, everything's in place for growth in 2015 and beyond. Here, he takes both a look back and a look forward

The Pipeline Report 2015: Dream Drugs

The Pipeline Report 2015: Dream Drugs

By

These 16 sprouts, from a field of 156, are looking up. With more nurturing, their buds could blossom. Marc Iskowitz reports

Data Management: Brace for the Breach

Data Management: Brace for the Breach

The specter of a massive hack is haunting the healthcare industry. As it turns out, that might not necessarily be a bad thing for everyone involved. Sarah Mahoney explains

CROs: Trial Blazing

CROs: Trial Blazing

Running clinical trials remains one of Big Pharma's biggest headaches. But thanks to canny use of social media, gamification techniques and even text messages, CROs have revitalized and revolutionized the process. Barbara Peck explains

Engaging HCPs: Inhospitable

Engaging HCPs: Inhospitable

By

Hospitals used to be much more welcoming to pharma sales reps than they are today. Larry Dobrow looks at how the rise of the hospitalist has changed the game plan for getting the word out about products

Informed Targeting: Target Practice

Informed Targeting: Target Practice

As traditional saturation detailing and speaker programs lose ground, the advent of big data and analytics is letting pharma companies reach prized prescribers through new techniques like informed targeting and dynamic marketing. ZS Associates' Pratap Khedkar and Malcolm Sturgis explain

Point of Care: Ready to Wear

Point of Care: Ready to Wear

For the last few years, technology companies have been far more bullish about the potential of wearable health devices than healthcare organizations, never mind the consumers who were supposedly so eager to embrace them. New research, however, reveals that wearables may finally be catching on. Parks Associates' Harry Wang explains

Cloud Marketing: Cloud Power

Cloud Marketing: Cloud Power

For all the talk about "the cloud," it promises most players in the pharma loop—sales and marketing execs, R&D teams and even the FDA—a better and faster way of doing business. Sarah Mahoney reports on how "the cloud" has become much more than a buzzword, and on what's inhibiting adoption

Therapeutic Focus 2014: Neurology

Therapeutic Focus 2014: Neurology

New therapies are shaking up MS and insomnia, while the slow pace of progress in Alzheimer's continues to frustrate patients and physicians alike. Welcome to neurology, where, Joe Dysart reports, treatment breakthroughs in certain areas are counteracted by setbacks in others

Leadership Exchange: Engaging the Digital Natives

Leadership Exchange: Engaging the Digital Natives

By

Striking the right tone in health communications with digital-savvy Millennials is tricky. Marc Iskowitz asks seven experts for some of the keys to facilitating that conversation

MM&M Awards 2014: Gazing at the Stars

MM&M Awards 2014: Gazing at the Stars

By

Standouts from the pharma, agency and media worlds aligned on the evening of October 2, as the industry saluted the winners of the 2014 MM&M Awards. Click on the slideshow below to see a gallery of pictures from the event

Career & Salary Survey: In Check

Career & Salary Survey: In Check

By

Salaries are down,the industry gender gap persists and people have their eyes peeled for better gigs. But job satisfaction remains positive and, compared with other businesses, the pay isn't half-bad. James Chase attempts to make sense of the seeming contradictions

Career Paths: The Climb

Career Paths: The Climb

By

As these eight pharma execs tell Larry Dobrow, achieving long-term success takes learning, listening, adapting and connecting with colleagues

Therapeutic Focus 2014: Vaccines

Therapeutic Focus 2014: Vaccines

The anti-vaccination movement continues to make noise, but the Ebola scare has highlighted the role vaccines play in controlling diseases—and saving lives. Joe Dysart looks at the implications of the quest for an anti-Ebola vaccine, as well as the corporate shakeup in the vaccine sector.

Recruitment: The New Breed

Recruitment: The New Breed

By

What do healthcare agencies really want when it comes to potential employees? The answer to that question is in a constant state of flux, as technologies, clients' changing demands and the ever-expanding skill sets of a new generation of job seekers are transforming the rules of recruitment and hiring. Larry Dobrow reports

Patient Education/ Marketing: Keeping Pace with Patients

Patient Education/ Marketing: Keeping Pace with Patients

By

Welcome to patient education circa 2014: With patient expectations at an all-time high, pharma marketers are struggling to keep up in the quest to make meaningful contact with tech-empowered audiences. But a few savvy companies seem to have cracked the communication code, moving to the forefront of this movement. Larry Dobrow reports

Therapeutic Focus 2014: Women's Health

Therapeutic Focus 2014: Women's Health

To see what's new in the women's health market, it might be necessary to take a look back. The return of the IUD is just one comeback shaping the future of a field that has never been a stranger to controversy. Noah Pines reports on the latest developments in this space

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

By

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what 2014's slight uptick means in the context of an evolving media mix

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

By

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the Pill?

By

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and opportunities

Biotech Report: Ultra Man

Biotech Report: Ultra Man

By

Innovation is still valued in the orphan-drug space, but the reimbursement bar is rising. NPS Pharma's Eric Pauwels, who's launched five ultra-rare disease products, explains how these biotech brands can demonstrate their value. Marc Iskowitz reports

Leadership Exchange: Thinking More Like a Patient

Leadership Exchange: Thinking More Like a Patient

By

A major information explosion is just the tip of the iceberg in the paradigm shift that is taking place between pharma, marketers and the patients that they serve. James Chase asks experts from across the patient-to-pharma spectrum how the industry can negotiate the new environment to successfully put patients first

Marketing Research: A Question of Value

Marketing Research: A Question of Value

When assessing the value of breakthrough drugs, Health Economics & Outcomes Research can help generate the economic profile of a new therapy. Mohan Bala and Meghan Gallagher explain its use

Therapeutic Focus 2014: Oncology

Therapeutic Focus 2014: Oncology

Immunotherapy is an emerging powerhouse in cancer treatment. Early gains being made in multiple tumor types provide a glimpse of the effectiveness of several agents and regimens. While longer follow-up is needed, the results have analysts talking about a big shift in the war on cancer. Joe Dysart reports

Multichannel Marketing: At Your Service

Multichannel Marketing: At Your Service

Pharma is moving toward a broader treatment paradigm based on providing additional services for patients. Boris Kushkuley describes what the Pill+ model looks like, and how multichannel marketing can facilitate it

MM&M Awards 2014: The Final Cut

MM&M Awards 2014: The Final Cut

By

More than 100 esteemed industry leaders and thinkers spent several hours discussing, reviewing and scoring around 700 entries to the MM&M Awards. Here are the results of their efforts—the 2014 finalists

Headliner: Galderma CEO confronts challenges

Headliner: Galderma CEO confronts challenges

By

Stuart Raetzman, CEO, Galderma Labs

Lions Health sets the bar for creativity

Lions Health sets the bar for creativity

By

The inaugural Lions Health festival of creativity in healthcare communciations was a big success

Top 100 Agencies 2014: AbelsonTaylor

Top 100 Agencies 2014: AbelsonTaylor

By

A history of doing the unexpected has kept AT at the top of its game

Top 100 Agencies 2014: The Access Group

Top 100 Agencies 2014: The Access Group

Following a diversified path leads agency to a "significant" year

Top 100 Agencies 2014: AgencyRx

Top 100 Agencies 2014: AgencyRx

By

CDM shop makes it to the agency A-list thanks to a diverse skill set

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.

Email Newsletters